tryptophan has been researched along with cyclin d1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balbín, M; Ferrando, AA; Fueyo, A; Hannon, GJ; López-Otín, C; Pendás, AM; Vizoso, F | 1 |
Sun, T; Tian, H; Xin, Y | 1 |
2 other study(ies) available for tryptophan and cyclin d1
Article | Year |
---|---|
Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases.
Topics: Arginine; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Primers; Female; Humans; Molecular Sequence Data; Oncogene Proteins; Point Mutation; Protein Binding; Structure-Activity Relationship; Tryptophan | 1996 |
1-butyltryptophan inhibits cell proliferation, migration, and invasion through the Akt pathway in human gastric cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Humans; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Stomach Neoplasms; Tryptophan | 2015 |